Article Details
Retrieved on: 2021-03-08 16:06:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company develops monoclonal antibodies to treat autoimmune diseases. It was set back last month, saying it voluntarily paused dosing in its ...
Article found on: www.thestreet.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here